Fig. 1From: Cost utility analysis of the SQ® HDM SLIT-tablet in house dust mite allergic asthma patients in a German settingGraphical representation of change in patient utility over time, for each of the three scenarios assessed. Within all three scenarios, utility scores were based on results from the end of the treatment maintenance period in MT-04. For all remaining years, utility scores were altered via an annual rate of change, to see the impact long-term changes in patient outcomes had on the results. The rates of change in each scenario are given here in tableBack to article page